EnChroma wearable tech corrects color blindness

Article

EnChroma has designed digital lenses that correct for colorblindness.

Berkeley, CA-EnChroma has designed digital lenses that correct for color blindness.

Designers developed a mathematical model of how the brain processes color and determined how to accomplish the necessary digital spectral processing with a complex coating system. The coating consists of a stack of more than 100 layers of semi-reflective material.

"By controlling the thickness of each layer to nanometer-scale precision, sharp edges can be created in the spectrum where the transmission abruptly changes to pass or block specific wavelengths of light, which is analogous to how a digital electrical signal instantaneously changes between the binary states of 0 and 1," said Andrew W. Schmeder, EnChroma's vice president of technology. "That is what we mean by digital spectral processing: the ability to make a series of precisely designed incisions along the spectrum to enhance primary colors while cutting out the intermediate wavelengths of light that dilute the color signal received by the brain."

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.